T1 and T2 measurements across multiple 0.55T MRI systems using open‐source vendor‐neutral sequences
Magnetic Resonance in Medicine · 2025-01 · 93 (1) · 289-300
DOI: 10.1002/mrm.30281 ↗Kurz gefasst
Fachartikel in der Zeitschrift Magnetic Resonance in Medicine, 2024-09. Verfasst von Kathryn E Keenan und 9 weiteren Autor:innen. Beteiligte Einrichtung: National Institute of Standards and Technology, Boulder, Colorado, USA. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Phantoms, Imaging. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS, National Institutes of Health, Intramural Research Program, National Heart Lung and Blood Institute, National Science Foundation.
Abstract (Originalsprache)
Purpose
To compare T1 and T2 measurements across commercial and prototype 0.55T MRI systems in both phantom and healthy participants using the same vendor‐neutral pulse sequences, reconstruction, and analysis methods.
Methods
Standard spin echo measurements and abbreviated protocol measurements of T1, B1, and T2 were made on two prototype 0.55 T systems and two commercial 0.55T systems using an ISMRM/NIST system phantom. Additionally, five healthy participants were imaged at each system using the abbreviated protocol for T1, B1, and T2 measurement. The phantom measurements were compared to NMR‐based reference measurements to determine accuracy, and both phantom and in vivo measurements were compared to assess reproducibility and differences between the prototype and commercial systems.
Results
Vendor‐neutral sequences were implemented across all four systems, and the code for pulse sequences and reconstruction is freely available. For participants, there was no difference in the mean T1 and T2 relaxation times between the prototype and commercial systems. In the phantom, there were no significant differences between the prototype and commercial systems for T1 and T2 measurements using the abbreviated protocol.
Conclusion
Quantitative T1 and T2 measurements at 0.55T in phantom and healthy participants are not statistically different across the prototype and commercial systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- National Institute of Standards and Technology, Boulder, Colorado, USA.
- Ming Hsieh Department of Electrical and Computer Engineering, University of Southern California, Los Angeles, California, USA.
- Cardiovascular Branch, Division of Intramural Research, National Heart, Lung, Blood Institute, National Institutes of Health, Bethesda, Maryland, USA.
- Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Kathryn E Keenan, Bilal Tasdelen, Ahsan Javed, Adrienne E Campbell-Washburn, Krishna S Nayak
Förderung
- Intramural NIH HHS
- National Institutes of Health, Intramural Research Program, National Heart Lung and Blood Institute
- National Science Foundation
Zitieren
APA
Keenan, K. E., Tasdelen, B., Javed, A., Ramasawmy, R., Rizzo, R., Martin, M. N., Stupic, K. F., Seiberlich, N., Campbell-Washburn, A. E., & Nayak, K. S. (2025). T1 and T2 measurements across multiple 0.55T MRI systems using open‐source vendor‐neutral sequences. Magnetic Resonance in Medicine, 93(1), 289-300. https://doi.org/10.1002/mrm.30281
Vancouver
Keenan KE, Tasdelen B, Javed A, Ramasawmy R, Rizzo R, Martin MN, et al. T1 and T2 measurements across multiple 0.55T MRI systems using open‐source vendor‐neutral sequences. Magnetic Resonance in Medicine. 2025;93(1):289-300. doi:10.1002/mrm.30281
BibTeX
@article{Keenan2025,
author = {Keenan, Kathryn E and Tasdelen, Bilal and Javed, Ahsan and Ramasawmy, Rajiv and Rizzo, Rudy and Martin, Michele N and Stupic, Karl F and Seiberlich, Nicole and Campbell-Washburn, Adrienne E and Nayak, Krishna S},
title = {T1 and T2 measurements across multiple 0.55T MRI systems using open‐source vendor‐neutral sequences},
journal = {Magnetic Resonance in Medicine},
year = {2025},
volume = {93},
number = {1},
pages = {289--300},
doi = {10.1002/mrm.30281}
}
EUVIMED